![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0097.png)
97
[130] S. L. Hyman, A. Shores, and K. N. North, “The nature and frequency of cognitive deficits in children
with neurofibromatosis type 1,”
Neurology
, vol. 65, no. 7, pp. 1037–44, 2005.
[131] D. A. Stevenson, M. Murray, D. H. Viskochil, J. C. Carey, and L. J. Moyer-Mileur, “Bone mineral
density in children with neurofibromatosis type 1,”
J. Pediatr. Orthop.
, vol. 28, no. 7, p. 791; author reply
791–792, Nov. 2008.
[132] J. F. Souza, R. L. F. Passos, A. C. M. Guedes, N. A. Rezende, and L. O. C. Rodrigues, “Muscular force is
reduced in neurofibromatosis type 1,”
J. Musculoskelet. Neuronal Interact.
, vol. 9, no. 1, pp. 15–17, Mar.
2009.
[133] A. K. Licis, A. Vallorani, F. Gao, C. Chen, J. Lenox, K. A. Yamada, S. P. Duntley, and D. H. Gutmann,
“Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1,”
J. Child Neurol.
, vol. 28,
no. 11, pp. 1400–1405, Nov. 2013.
[134] G. D. Leschziner, J. F. Golding, and R. E. Ferner, “Sleep disturbance as part of the neurofibromatosis
type 1 phenotype in adults,”
Am. J. Med. Genet. A.
, vol. 161, no. 6, pp. 1319–1322, 2013.
[135] H. L. Thompson, D. H. Viskochil, D. A. Stevenson, and K. L. Chapman, “Speech-language
characteristics of children with neurofibromatosis type 1,”
Am. J. Med. Genet. A.
, vol. 152A, no. 2, pp.
284–290, Feb. 2010.
[136] M. Cosyns, L. Vandeweghe, G. Mortier, S. Janssens, and J. Van Borsel, “Speech disorders in
neurofibromatosis type 1: a sample survey,”
Int. J. Lang. Commun. Disord. R. Coll. Speech Lang. Ther.
,
vol. 45, no. 5, pp. 600–607, Oct. 2010.
[137] N. A. Pride and K. N. North, “The Cognitive Profile of NF1 Children: Therapeutic Implications,” in
Neurofibromatosis Type 1
, M. Upadhyaya and D. N. Cooper, Eds. Springer Berlin Heidelberg, 2012, pp.
55–69.
[138] L. C. Krab and A. B. Rietman, “Niet altijd zichtbaar. Sociaal-emotionele en leerproblemen bij kinderen
en jongeren met NF1. Informatie en tips voor ouders, kinderen, jongeren, leerkrachten en begeleiders.,”
Feb. 2014.
[139] J. Sangster, E. A. Shores, S. Watt, and K. N. North, “The cognitive profile of preschool-aged children
with neurofibromatosis type 1,”
Child Neuropsychol
, vol. 17, no. 1, pp. 1–16.
[140] V.-F. Mautner, S. Granström, and R. A. Leark, “Impact of ADHD in Adults With Neurofibromatosis
Type 1: Associated Psychological and Social Problems,”
J. Atten. Disord.
, Jul. 2012.
[141] Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ, “Multidisciplinaire Richtlijn
voor diagnostiek en behandeling van ADHD bij kinderen en jeugdigen.” 2005.
[142] S. Garg, J. Green, K. Leadbitter, R. Emsley, A. Lehtonen, D. G. Evans, and S. M. Huson,
“Neurofibromatosis type 1 and autism spectrum disorder,”
Pediatrics
, vol. 132, no. 6, pp. e1642–1648,
Dec. 2013.
[143] Nederlandse Vereniging voor Psychiatrie and Nederlands Instituut voor Psychologie, “Richtlijn
diagnostiek en behandeling autismespectrumstoornissen bij kinderen en jeugdigen.” De Tijdstroom
uitgeverij BV, 2009.
[144] Nederlandse Vereniging voor Psychiatrie and Nederlands Instituut voor Psychologie, “Richtlijn
diagnostiek en behandeling autismespectrumstoornissenbij volwassenen.” Utrecht, 2013.
[145] K. J. Hofman, E. L. Harris, R. N. Bryan, and M. B. Denckla, “Neurofibromatosis type 1: the cognitive
phenotype,”
J. Pediatr.
, vol. 124, no. 4, pp. S1–8, Apr. 1994.
[146] V. Sánchez-Huerta, A. A. Rodríguez-Reyes, E. Hernández-Quintela, M. Ramírez, H. A. Rodríguez-
Martínez, and R. Naranjo-Tackman, “A corneal diffuse neurofibroma as a manifestation of von
recklinghausen disease,”
Cornea
, vol. 22, no. 1, pp. 59–62, Jan. 2003.
[147] Samenwerkende oogcentra van de Samenwerkende Topklinische Ziekenhuizen, “Glaucoom (hoge
oogdruk).” [Online]. Available:
http://www.oogartsen.nl/oogartsen/overige_oogziekten/glaucoom_glaucoma_oogdruk/.[Accessed: 10-
Jul-2014].